Botulinum toxin treatment of axial and cervical dystonia

Disability and Rehabilitation

Volumn 29, Issue 23, 2007, Pages 1769-1777

  Benecke, Reiner ^a   Dressler, Dirk ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Axial dystonia; Botulinum toxin; Cervical dystonia

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CORTICOSTEROID;

BODY POSTURE; BRACHIAL PLEXUS NEUROPATHY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DYSPHAGIA; DYSTONIA; ELECTROMYOGRAPHY; HEAD AND NECK DISEASE; HOARSENESS; HUMAN; MUSCLE CONTRACTURE; NECK PAIN; NEURITIS; PARESIS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SHOULDER PAIN; SIDE EFFECT; SYMPTOM; TORTICOLLIS; TREATMENT OUTCOME; VIDEORECORDING; WEAKNESS; XEROSTOMIA;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; DYSTONIA; ELECTROMYOGRAPHY; HUMANS; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; TORTICOLLIS;

EID: 36549038211     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.1080/01421590701568262     Document Type: Review

References (40)

1. Foltz, E. L., Knopp, L. M. and Ward, A. A. (1959) Experimental spasmodic torticollis. J Neurosurg, 16, pp. 55-72.
2. Comella, C. L., Shannon, K. M. and Jaglin, J. (1998) Extensor truncal dystonia: Successful treatment with botulinum toxin injections. Mov Disord, 13, pp. 552-555.
3. Kupsch, A., Benecke, R. and Mueller, J. (2006) Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med, 355, pp. 1978-1990.
4. Tsui, J. K., Eisen, A., Mak, E., Carruthers, J., Scott, A. and Calne, D. B. (1985) A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci, 12, pp. 314-316.
5. Tsui, J. K., Eisen, A., Stoesl, A. J., Calne, S. and Calne, D. B. (1986) Double-blind study of botulinum toxin in spasmodic torticollis. Lancet, 2, pp. 245-247.
6. Lorentz, I. T., Subramaniam, S. S. and Yiannikas, C. (1991) Treatment of idiopathic spasmodic torticollis with botulinum toxin A: A double-blind study on 23 patients. Mov Disord, 6, pp. 145-150.
7. Blackie, J. D. and Lees, A. J. (1990) Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry, 53, pp. 640-643.
8. Moore, A. P. and Blumhardt, L. D. (1991) A double blind trial of botulinum toxin 'A' in torticollis, with one-year follow-up. J Neurol Neurosurg Psychiatry, 54, pp. 813-816.
9. Anderson, T. J., Rivest, J. and Stell, R. (1992) Botulinum-toxin treatment of spasmodic torticollis. J R Soc Med, 85, pp. 524-529.
10. Gelb, D. J., Lowenstein, D. H. and Aminoff, M. J. (1989) Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology, 39, pp. 80-84.
11. Jankovic, J. and Schwartz, P. A. (1990) Botulinum toxin injections for cervical dystonia. Neurology, 40, pp. 277-280.
12. Kessler, K. R., Skutta, M. and Benecke, R. (1999) Long-term treatment of cervical dystonia with botulinum toxin A: Efficacy, safety, and antibody frequency. J Neurology, 246, pp. 265-274.
13. Naumann, M., Yakovleff, A. and Durif, F. (2002) A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin and current bold toxin source for the treatment of cervical dystonia. J Neurol, 249, pp. 57-63.
14. Dubinsky, R. M., Grey, C. S., Vetere-Overfield, B. and Koller, W. C. (1991) Electromyographic guidance of botulinum toxin treatment in cervical dystonia. Clin Neuropharmacol, 14, pp. 262-267.
15. Jankovic, J. and Brin, M. F. (1991) Therapeutic uses of botulinum toxin. N Engl J Med, 324, pp. 1186-1194.
16. Benecke, R., Jost, W. H., Kanovsky, M. D., Ruzicka, A., Comes, G. and Grafe, S. (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology, 64, pp. 1949-1951.
17. Stell, R., Thompson, P. D. and Marsden, C. D. (1988) Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry, 51, pp. 920-923.
18. Poewe, W., Schelosky, L., Kleedorfer, B., Heinen, F., Wagner, M. and Deuschl, G. (1992) Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients. J Neurol, 239, pp. 21-25.
19. Wissel, J. and Poewe, W. (1992) Dystonia - a clinical, neuropathological and therapeutic review. J Neural Transm Suppl, 38, pp. 91-104.
20. Lew, M. F., Adornato, B. T. and Duane, D. D. (1997) Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology, 49, pp. 701-707.
21. Habermann, E., Dreyer, F. and Bigalke, H. (1980) Tetanus toxin blocks the neuroimiscular transmission in vitro like botulinum A toxin. Naunyn Schmiedebergs Arch Pharmacol, 311, pp. 33-40.
22. Fahn, S., Marsden, C. D. and Calne, D. B. (1987) Classification and investigation of dystonia. Movement Disorders 2, pp. 332-358. Butterworths, London
23. Greene, P., Shale, H. and Fahn, S. (1988) Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord, 3, pp. 46-60.
24. Greene, P. (1992) Baclofen in the treatment of dystonia. Clin Neuropharmacol, 15, pp. 276-288.
25. Lang, A. E. (1988) Dopamine agonists and antagonists in the treatment of idiopathic dystonia. Adv Neurol, 50, pp. 561-570.
26. Lang, A. E. (1998) Surgical treatment of dystonia. Dystonia 3: Advances in Neurology, pp. 185-198. Lippincott-Raven Publ, Philadelphia
27. Jankovic, J. and Orman, J. (1988) Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology, 38, pp. 391-394.
28. Thiel, A., Dressler, D., Kistel, C. and Ruther, E. (1994) Clozapine treatment of spasmodic torticollis. Neurology, 44, pp. 957-958.
29. Ohara, S., Hayashi, R., Momoi, H., Miki, J. and Yanagisawa, N. (1998) Mexiletine in the treatment of spasmodic torticollis. Mov Disord, 13, pp. 934-940.
30. Dressler, D. and Benecke, R. (2003) Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol, 49, pp. 34-38.
31. Dressler, D. and Benecke, R. (2006) Pharmakologie der Botulinumtoxine. Nervenheilkunde, 25, pp. 521-526.
32. Bertrand, C. M. (1993) Selective peripheral denervation for spasmodic torticollis: Surgical technique, results, and observations in 260 cases. Surg Neurol, 40, pp. 96-103.
33. Davis, D. H., Ahlskog, J. E., Litchy, W. J. and Root, L. M. (1991) Selective peripheral denervation for torticollis: Preliminary results. Mayo Clin Proc, 66, pp. 365-371.
34. Brin, M. F., Lew, M. F., Adler, C. H., Comella, C. L., Factor, S. A., Jankovic, J., O'Brien, C., Murray, J. J., Wallace, J. D., Willmer-Hulme, A. and Koller, M. (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervicaldystonia. Neurology, 53:7, pp. 1431-1438.
35. Braun, V. and Richter, H-P (1994) Selective peripheral denervation for the treatment of spasmodic torticollis. Neurosurgery, 35, pp. 58-63.
36. Ford, B., Louis, E. D., Greene, P. and Fahn, S. (1998) Outcome of selective ramisectomy for botulinum toxin resistant torticollis. J Neurol Neurosurg Psychiatry, 65, pp. 472-478.
37. Zuber, M., Sebald, M., Bathien, N., Dercondo, J. and Rondot, P. (1993) Botulinum antibodies in dystonic patients treated with type-A botulinum toxin - frequence and significance. Neurology, 43, pp. 1715-1718.
38. Greene, P., Kang, U., Fahn, S., Brin, M., Moskowitz, C. and Flaster, E. (1990) Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology, 40, pp. 1213-1218.
39. Greene, P., Fahn, S. and Diamond, B. (1994) Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord, 9, pp. 213-217.
40. Duane, C., Clark, M., LaPointe, L. L. and Case, J. L. (1995) Botulinum toxin A antibodies in initial and delayed resistance to botulinum toxin A therapy in cervical dystonia. Mov Disord, 10, p. 394(A82).